Previous 10 | Next 10 |
Gainers : Anika Therapeutics (NASDAQ: ANIK ) +34% . TCR2 Therapeutics (NASDAQ: TCRR ) +30% . Diebold Nixdorf (NYSE: DBD ) +26% . EDAP TMS (NASDAQ: EDAP ) +20% . Hovnanian (NYSE: HOV ) +18%. NETGEAR (NASDAQ: NTGR ) +16% . Meritage Homes (NYSE: MTH ) +16% . Empire Resorts (NASDA...
Thinly traded Anika Therapeutics ( ANIK +34.7% ) is up on over 70% higher volume, albeit on turnover of only 291K shares, on the heels of its Q2 report released after the close yesterday. More news on: Anika Therapeutics, Inc., Healthcare stocks news, Earnings news and commentary, Stoc...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Anika Therapeutics Inc. (ANIK) Q2 2019 Results Earnings Conference Call July 24, 2019, 05:00 PM ET Company Participants Sylvia Cheung - Chief Financial Officer Joseph Darling - President and Chief Executive Officer Conference Call Participants Joe Munda - First Analysis Jim...
Anika Therapeutics (NASDAQ: ANIK ): Q2 GAAP EPS of $0.67 beats by $0.27 . More news on: Anika Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Delivers Strong Bottom Line Performance with $0.67 Diluted EPS CINGAL Revenue Drives International Viscosupplement Revenue Growth of 28% Year-over-Year Announces Decision to Advance CINGAL Program Towards U.S. Regulatory Approval Raises Full Year 2019 Revenue and Adjusted E...
AEM , AGNC , ALGN , ALGT , AMP , ANIK , APY , ARI , ASGN , AXTI , BCOV , BHE , CERN , CHFC , CLB , CLGX , CLS , CMRE , COR , CTXS , CUBI , CUZ , CVBF , ECHO , EFX , EGP , EIG , ESRT , ESS , F , FARO , FB , FFIV , FR , FTI , GGG , HLX , HNI , HP , ICLR...
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , today announced plans to exhibit its injectable, HA-based, surgical bone repair therapy...
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its second-quarter 2019 financial results after the close of the market on Wednesday, July 24, 2019 and hold its investor conference call on the same day, Wednesday, July 24, 2019, at 5:00 p.m. ET to dis...
Industry veteran brings extensive experience leading business development groups Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology , toda...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...